Guanidine Derivatives in Medicine
- 19 July 1973
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 289 (3) , 141-146
- https://doi.org/10.1056/nejm197307192890308
Abstract
FIFTY years have passed since the introduction of insulin into medicine. It is not widely known that guanidine derivatives were first used in the therapy of diabetes at about the same time, and that the effects of guanidine in a biologic system were first described nearly 100 years ago.1 Over the years, a wide variety of guanidine derivatives have become important investigational tools, as well as major therapeutic agents. Table 1 shows some of these compounds and the extensive range of their activities and uses. It is tempting to conclude that the common structural feature, the guanidine residue, confers no more specificity . . .Keywords
This publication has 30 references indexed in Scilit:
- Inhibition of gluconeogenesis from lactate by phenylethylbiguanide in the perfused guinea pig liverDiabetologia, 1972
- PHENFORMIN AND METABOLIC ACIDOSISThe Lancet, 1972
- Effects of Tetrodotoxin on Excitability of Squid Giant Axons in Sodium-Free MediaScience, 1967
- Enhanced Permeability to Sugar Associated with Muscle ContractionThe Journal of general physiology, 1967
- Specific Inhibition of Gluconeogenesis by BiguanidesNature, 1967
- The crystal structure of guanidinium chlorideActa Crystallographica, 1965
- Structural requirements for bretylium and guanethidine-like activity in a series of guanidine derivativesLife Sciences, 1962
- Hypoglycemic Agents. III.1—3 N1-Alkyl- and AralkylbiguanidesJournal of the American Chemical Society, 1959
- Die Wirkung des Biguanids und seiner Derivate auf den ZuckerstoffwechselNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1929
- Über die GuanidinhypoglykämieNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1926